Use AI agents to predict drug-induced liver injury (DILI), the biggest cause of clinical trial failure after lack of efficacy. Build intelligent systems to curate data and predict hepatotoxicity.
Drug-Induced Liver Injury (DILI) is the leading cause of clinical trial failure after lack of efficacy, resulting in billions of dollars in wasted investment and delayed therapeutic development.
Current approaches to predicting hepatotoxicity are limited by fragmented data sources and the inability to systematically integrate diverse biological signals — from in vitro assays to clinical outcomes.
AI agents offer a solution: intelligent systems that can autonomously curate data from multiple sources, identify mechanistic patterns, and build predictive models that could save years of development time and countless lives.
Your mission is to build AI agents that predict drug-induced liver injury by intelligently curating and integrating data from diverse sources.
You can manually search for data or use agents to curate it. Data can be clinical, in vitro, computational, or anything else that gives signal. The key is finding creative sources and intelligent ways to integrate them.
Official FDA benchmark data for DILI prediction
Industry-standard benchmarks and test sets
Clinical trial data including adverse events
Bioactive molecules with drug-like properties
Gene expression responses to chemical perturbations
Cell Painting dataset for morphological profiling
Toxicity and ADME high-throughput data
💡 Pro Tip: Build agents to scrape mechanistic information from literature, correlate chemical structures with toxicity pathways, or integrate multi-omics data for deeper insights.
Well-documented code showing how your agents curate data and what sources they use
The structured dataset your agents assembled, with clear documentation of sources and features
Trained models with clear architecture, training methodology, and performance metrics
Notebook/script that takes test data, removes overlapping training examples, and returns predictions
Clear explanation of your approach, data sources, feature engineering, and modeling decisions
If enough participants choose to predict DILI, we will evaluate models on internal Axiom data and release comparative results.
Your evaluation script will be run on this blind test set to assess real-world predictive performance.